Essex Savings Bank’s Bristol-Myers Squibb BMY Stock Holding History

Essex Savings Bank’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$779K	Sell	13,528 -309	-2%	-$17.7K	0.17%	123
2026 Q1	$839K	Sell	13,837 -744	-5%	-$43.4K	0.19%	110
2025 Q4	$786K	Sell	14,581 -564	-4%	-$27.1K	0.17%	114
2025 Q3	$683K	Sell	15,145 -1,529	-9%	-$71.4K	0.15%	129
2025 Q2	$772K	Sell	16,674 -830	-5%	-$40.7K	0.18%	109
2025 Q1	$1.07M	Buy	17,504 +72	+0.4%	+$4.2K	0.26%	87
2024 Q4	$986K	Buy	17,432 +733	+4%	+$41K	0.24%	87
2024 Q3	$864K	Buy	16,699 +948	+6%	+$44.5K	0.22%	103
2024 Q2	$654K	Sell	15,751 -768	-5%	-$34.4K	0.18%	117
2024 Q1	$848K	Hold	16,519	–	–	0.25%	99
2023 Q4	$848K	Sell	16,519 -4,878	-23%	-$256K	0.25%	99
2023 Q3	$1.24M	Sell	21,397 -129	-0.6%	-$7.9K	0.42%	53
2023 Q2	$1.38M	Sell	21,526 -82	-0.4%	-$5.5K	0.46%	50
2023 Q1	$1.5M	Buy	21,608 +3	+0%	+$212	0.52%	43
2022 Q4	$1.55M	Buy	21,605 +358	+2%	+$27K	0.55%	39
2022 Q3	$1.51M	Sell	21,247 -40	-0.2%	-$2.9K	0.6%	35
2022 Q2	$1.64M	Sell	21,287 -713	-3%	-$54.3K	0.63%	35
2022 Q1	$1.61M	Buy	22,000 +420	+2%	+$28.2K	0.53%	46
2021 Q4	$1.35M	Buy	21,580 +866	+4%	+$50.8K	0.46%	51
2021 Q3	$1.39M	Buy	20,714 +689	+3%	+$45.4K	0.5%	48
2021 Q2	$1.32M	Sell	20,025 -215	-1%	-$14K	0.51%	49
2021 Q1	$1.24M	Sell	20,240 -9	-0%	-$560	0.54%	46
2020 Q4	$1.26M	Buy	20,249 +220	+1%	+$13.5K	0.56%	46
2020 Q3	$1.21M	Buy	20,029 +2,361	+13%	+$142K	0.59%	41
2020 Q2	$1.04M	Sell	17,668 -213	-1%	-$12.7K	0.62%	42
2020 Q1	$997K	Sell	17,881 -1,596	-8%	-$97.5K	0.71%	38
2019 Q4	$1.25M	Buy	19,477 +3,143	+19%	+$180K	0.64%	43
2019 Q3	$828K	Sell	16,334 -6,532	-29%	-$307K	0.44%	59
2019 Q2	$1.04M	Buy	22,866 +10,566	+86%	+$492K	0.36%	59
2019 Q1	$587K	Sell	12,300 -150	-1%	-$7.47K	0.33%	69
2018 Q4	$647K	Buy	+12,450	New	+$669K	0.41%	57

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Essex Savings Bank's BMY Position: Q2 2026 in Review

Essex Savings Bank reduced its Bristol-Myers Squibb (BMY) stake by 2.2% in Q2 2026, selling an estimated $17.7K and leaving 13,528 shares worth $779K. The position accounts for 0.17% of the portfolio, ranked #123.

Essex Savings Bank first reported a position in BMY in Q4 2018 and has held it in 31 quarters since. The position peaked at $1.64M in Q2 2022. 1,603 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Essex Savings Bank held 13,528 shares of Bristol-Myers Squibb worth $779K as of Q2 2026.
Essex Savings Bank sold 309 Bristol-Myers Squibb shares in Q2 2026, an estimated $17.7K.
Bristol-Myers Squibb made up 0.17% of Essex Savings Bank's portfolio in Q2 2026, its #123 holding.
Essex Savings Bank first reported a position in Bristol-Myers Squibb in Q4 2018 and has held it in 31 quarters since.
Essex Savings Bank's Bristol-Myers Squibb position peaked at $1.64M in Q2 2022.
1,603 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Essex Savings Bank's 13F filing for Q2 2026, filed 23 Jul 2026.